Yunnan Baiyao Group Co Ltd
SZSE:000538
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
46.17
62.68
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Yunnan Baiyao Group Co Ltd
Yunnan Baiyao Group Co Ltd
Long-Term Investments
Yunnan Baiyao Group Co Ltd
Long-Term Investments Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Long-Term Investments
¥12.7B
|
CAGR 3-Years
122%
|
CAGR 5-Years
27%
|
CAGR 10-Years
68%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Long-Term Investments
¥684.7m
|
CAGR 3-Years
189%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Long-Term Investments
¥571.9m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-1%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Long-Term Investments
¥1.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
53%
|
CAGR 10-Years
77%
|
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Long-Term Investments
¥764.5m
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Long-Term Investments
¥1.6m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yunnan Baiyao Group Co Ltd
Glance View
Yunnan Baiyao Group Co Ltd is a captivating story of fusion between traditional Chinese medicine and modern business acumen. Rooted in Yunnan province's rich heritage, the company traces its origins back to the early 1900s when a local healer discovered a potent remedy for addressing wounds and reducing bleeding. Over the years, this original formula, a tightly-kept secret, evolved into a cornerstone product that propelled Yunnan Baiyao into the spotlight. As the company expanded, it embraced an adept strategy of integrating traditional formulations with contemporary pharmaceutical practices, enabling it to carve out a niche within the global health sector. Today, Yunnan Baiyao Group boasts a diversified portfolio that extends beyond its flagship product to include various health care, personal care, and even veterinary offerings. Its revenue model intricately weaves together streams from over-the-counter remedies, prescription medications, and consumer healthcare products. The company's innovative stride into the realms of cosmetics and toothpaste indicates its agility in adapting ancient knowledge for contemporary consumer demands. Strategic marketing emphasizes the unique heritage and trusted efficacy of its products, helping Yunnan Baiyao solidify its standing in a competitive market. As it continues to grow, the group remains a compelling example of how deeply-rooted tradition can be harnessed to drive a modern enterprise to sustained profitability.
See Also
What is Yunnan Baiyao Group Co Ltd's Long-Term Investments?
Long-Term Investments
12.7B
CNY
Based on the financial report for Sep 30, 2024, Yunnan Baiyao Group Co Ltd's Long-Term Investments amounts to 12.7B CNY.
What is Yunnan Baiyao Group Co Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
68%
Over the last year, the Long-Term Investments growth was 6%. The average annual Long-Term Investments growth rates for Yunnan Baiyao Group Co Ltd have been 122% over the past three years , 27% over the past five years , and 68% over the past ten years .
You don't have any saved screeners yet
